News About: Pharm. Industry
Provision of Drug Specific Prescription Forms Stirs Controversy
It has been discovered that certain number of domestic pharmaceutical firms are supplying free copies of prescription forms to the dental clinics, according to the Korea Pharmaceutical Association (KPA).
These pres...
GSK Korea Recalls Paxil with Certain Batch Identification Numbers
GlaxoSmithKline (GSK) Korea is currently making a request towards the pharmaceutical industry constituents to help in the recall process of its controlled release antidepressant Paxil CR (paroxetin HCl) with certain b...
Abbott Korea Announces Year 2004 Financial Results
According to Year 2004 financial results released by Abbott Korea last week, the company reported its total revenue of 107.47 billion won, which is up 4.6% from the prior fiscal year.
Looking at the total revenue b...
Increased Licensing-In Activities by Domestic Firms
A number of domestic pharmaceutical firms are undertaking the licensing-in activities to introduce competitive products in the domestic ethical medication market, and the industry expects that such introductions will ...
Choongwae with Export Sales Growth Prospect
From a recent market analysis on the domestic pharmaceutical firms released by Hanyang Securities, Choongwae Pharma is selected as the top prospect for its international growth potential for the current year and forwa...
Maxmavil, Amlodipin Receive Korea New Drug Awards
The Korea Drug Research Association (KDRA) selected Maxmavil by Yuyu Inc. and Amlodipin by Hanmi Pharmaceutical as the Korea New Drug Award recipients, where the award ceremony was held last week at the Seoul National...
Expansion of Domestic Pharmaceutical Exports to Advanced Countries
The export sales of bulk and finished pharmaceuticals that are manufactured by domestic companies are currently being expanded into the advanced countries in the world, including the United States, Europe, and Japan, ...
First GMP Accreditation Obtained by Nutraceutical Company
Natural Food & Pharmaceuticals Corp., a domestic maker specialized in nutraceutical products, announced last week that it has successfully received a GMP (Good Manufacturing Practice) certification from the Korea Food...
Green Cross Plans to Launch Mass Production of Human Placenta Injectable Preparations
Green Cross Holdings and Japan Bioproducts Industry Co. Ltd (Tokyo, Japan) recently agreed to form a joint venture to launch a domestic mass production of human placenta injectable preparations, with an expected start...
Dong-A Introduces Upgraded Version of Bacchus
Dong-A Pharmaceutical announced of its plan to introduce Bacchus-D, an upgraded version of existing Bacchus-F, an over-the-counter (OTC) tonic drink with high recognition and popularity in the domestic market.
The ...
